{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:28:36Z","timestamp":1794619716606,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"AC Immune","id":[{"id":"https:\/\/ror.org\/00e8cky09","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64540-6","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:02:29Z","timestamp":1761296549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Development of [18F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology"],"prefix":"10.1038","volume":"16","author":[{"given":"Efthymia","family":"Vokali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Charmey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Melly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monisha","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia M.","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jaquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Ravache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Scial\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Kroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-3206","authenticated-orcid":false,"given":"Francesca","family":"Capotosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Luthi-Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Afroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madiha","family":"Derouazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian C.","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-7527","authenticated-orcid":false,"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1356-9074","authenticated-orcid":false,"given":"Emanuele","family":"Buratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1271-9445","authenticated-orcid":false,"given":"Magdalini","family":"Polymenidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kosco-Vilbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8491-2706","authenticated-orcid":false,"given":"Tamara","family":"Seredenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"64540_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133 (2006).","journal-title":"Science"},{"key":"64540_CR2","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys. Res. Commun. 351, 602\u2013611 (2006).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"64540_CR3","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"64540_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","volume":"67","author":"K Uryu","year":"2008","unstructured":"Uryu, K. et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J. Neuropathol. Exp. Neurol. 67, 555\u2013564 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"64540_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","volume":"117","author":"T Arai","year":"2009","unstructured":"Arai, T. et al. Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies. Acta Neuropathol. 117, 125\u2013136 (2009).","journal-title":"Acta Neuropathol."},{"key":"64540_CR6","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/NEN.0b013e3181ee7d85","volume":"69","author":"AC McKee","year":"2010","unstructured":"McKee, A. C. et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918\u2013929 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"64540_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A. & Patel, B. K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 12, 25 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"64540_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1515\/REVNEURO.2010.21.4.251","volume":"21","author":"SJ Barmada","year":"2010","unstructured":"Barmada, S. J. & Finkbeiner, S. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways. Rev. Neurosci. 21, 251\u2013272 (2010).","journal-title":"Rev. Neurosci."},{"key":"64540_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jnc.13588","volume":"138","author":"IR Mackenzie","year":"2016","unstructured":"Mackenzie, I. R. & Neumann, M. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J. Neurochem. 138, 54\u201370 (2016).","journal-title":"J. Neurochem."},{"key":"64540_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns, N. J. et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 114, 5\u201322 (2007).","journal-title":"Acta Neuropathol."},{"key":"64540_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41572-023-00447-0","volume":"9","author":"M Grossman","year":"2023","unstructured":"Grossman, M. et al. Frontotemporal lobar degeneration. Nat. Rev. Dis. Prim. 9, 40 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"64540_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","volume":"138","author":"I Kawakami","year":"2019","unstructured":"Kawakami, I., Arai, T. & Hasegawa, M. The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol. 138, 751\u2013770 (2019).","journal-title":"Acta Neuropathol."},{"key":"64540_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chio","year":"2009","unstructured":"Chio, A. et al. Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 10, 310\u2013323 (2009).","journal-title":"Amyotroph. Lateral Scler."},{"key":"64540_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ana.23937","volume":"74","author":"J Brettschneider","year":"2013","unstructured":"Brettschneider, J. et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann. Neurol. 74, 20\u201338 (2013).","journal-title":"Ann. Neurol."},{"key":"64540_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz, G. M. et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65, 586\u2013590 (2005).","journal-title":"Neurology"},{"key":"64540_CR16","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/brain\/awr195","volume":"134","author":"JR Burrell","year":"2011","unstructured":"Burrell, J. R., Kiernan, M. C., Vucic, S. & Hodges, J. R. Motor neuron dysfunction in frontotemporal dementia. Brain 134, 2582\u20132594 (2011).","journal-title":"Brain"},{"key":"64540_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/jnen\/nlab050","volume":"80","author":"PT Nelson","year":"2021","unstructured":"Nelson, P. T. LATE neuropathologic changes with little or no Alzheimer disease is common and is associated with cognitive impairment but not frontotemporal dementia. J. Neuropathol. Exp. Neurol. 80, 649\u2013651 (2021).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"64540_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41582-023-00846-7","volume":"19","author":"S Nag","year":"2023","unstructured":"Nag, S. & Schneider, J. A. Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases. Nat. Rev. Neurol. 19, 525\u2013541 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"64540_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","volume":"144","author":"PT Nelson","year":"2022","unstructured":"Nelson, P. T. et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 144, 27\u201344 (2022).","journal-title":"Acta Neuropathol."},{"key":"64540_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae183","volume":"6","author":"N Corriveau-Lecavalier","year":"2024","unstructured":"Corriveau-Lecavalier, N. et al. Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome. Brain Commun. 6, fcae183 (2024).","journal-title":"Brain Commun."},{"key":"64540_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14202","volume":"21","author":"DA Wolk","year":"2025","unstructured":"Wolk, D. A. et al. Clinical criteria for limbic-predominant age-related TDP-43 encephalopathy. Alzheimers Dement. 21, e14202 (2025).","journal-title":"Alzheimers Dement."},{"key":"64540_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie, I. R. et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 122, 111\u2013113 (2011).","journal-title":"Acta Neuropathol."},{"key":"64540_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-030-51140-1_13","volume":"1281","author":"M Neumann","year":"2021","unstructured":"Neumann, M., Lee, E. B. & Mackenzie, I. R. Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance. Adv. Exp. Med. Biol. 1281, 201\u2013217 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"64540_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00401-023-02580-2","volume":"146","author":"M Neumann","year":"2023","unstructured":"Neumann, M. et al. Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology. Acta Neuropathol. 146, 163\u2013166 (2023).","journal-title":"Acta Neuropathol."},{"key":"64540_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s41586-023-06405-w","volume":"620","author":"D Arseni","year":"2023","unstructured":"Arseni, D. et al. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620, 898\u2013903 (2023).","journal-title":"Nature"},{"key":"64540_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-021-04199-3","volume":"601","author":"D Arseni","year":"2022","unstructured":"Arseni, D. et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601, 139\u2013143 (2022).","journal-title":"Nature"},{"key":"64540_CR27","doi-asserted-by":"publisher","unstructured":"Arseni, D. et al. Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP Type C. Nature, https:\/\/doi.org\/10.1038\/s41586-024-08024-5 (2024).","DOI":"10.1038\/s41586-024-08024-5"},{"key":"64540_CR28","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/nan.12732","volume":"47","author":"S Porta","year":"2021","unstructured":"Porta, S. et al. Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo. Neuropathol. Appl. Neurobiol. 47, 1033\u20131049 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"64540_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","volume":"22","author":"F Laferriere","year":"2019","unstructured":"Laferriere, F. et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 22, 65\u201377 (2019).","journal-title":"Nat. Neurosci."},{"key":"64540_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1155\/2009\/609839","volume":"21","author":"GD Rabinovici","year":"2009","unstructured":"Rabinovici, G. D. & Jagust, W. J. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav. Neurol. 21, 117\u2013128 (2009).","journal-title":"Behav. Neurol."},{"key":"64540_CR31","doi-asserted-by":"publisher","first-page":"13S","DOI":"10.2967\/jnumed.121.263195","volume":"63","author":"M Chapleau","year":"2022","unstructured":"Chapleau, M., Iaccarino, L., Soleimani-Meigooni, D. & Rabinovici, G. D. The role of amyloid PET in imaging neurodegenerative disorders: a review. J. Nucl. Med. 63, 13S\u201319S (2022).","journal-title":"J. Nucl. Med"},{"key":"64540_CR32","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy, A. et al. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol. Psychiatry 24, 1112\u20131134 (2019).","journal-title":"Mol. Psychiatry"},{"key":"64540_CR33","doi-asserted-by":"publisher","first-page":"20S","DOI":"10.2967\/jnumed.121.263196","volume":"63","author":"C Groot","year":"2022","unstructured":"Groot, C., Villeneuve, S., Smith, R., Hansson, O. & Ossenkoppele, R. Tau PET Imaging in Neurodegenerative Disorders. J. Nucl. Med. 63, 20S\u201326S (2022).","journal-title":"J. Nucl. Med."},{"key":"64540_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42305-3","volume":"14","author":"R Smith","year":"2023","unstructured":"Smith, R. et al. The alpha-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases. Nat. Commun. 14, 6750 (2023).","journal-title":"Nat. Commun."},{"key":"64540_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med"},{"key":"64540_CR36","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","volume":"20","author":"G Yadollahikhales","year":"2023","unstructured":"Yadollahikhales, G. & Rojas, J. C. Anti-Amyloid Immunotherapies for Alzheimer\u2019s disease: a 2023 clinical update. Neurotherapeutics 20, 914\u2013931 (2023).","journal-title":"Neurotherapeutics"},{"key":"64540_CR37","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","volume":"77","author":"M Brendel","year":"2020","unstructured":"Brendel, M. et al. Assessment of 18F-PI-2620 as a biomarker in progressive Supranuclear Palsy. JAMA Neurol. 77, 1408\u20131419 (2020).","journal-title":"JAMA Neurol."},{"key":"64540_CR38","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2018.12917","volume":"320","author":"R Ossenkoppele","year":"2018","unstructured":"Ossenkoppele, R. et al. Discriminative accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer disease vs other neurodegenerative disorders. Jama 320, 1151\u20131162 (2018).","journal-title":"Jama"},{"key":"64540_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee, E. B. et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. 134, 65\u201378 (2017).","journal-title":"Acta Neuropathol."},{"key":"64540_CR40","doi-asserted-by":"publisher","unstructured":"Scialo, C. et al. Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures. Neuron, https:\/\/doi.org\/10.1016\/j.neuron.2025.03.008 (2025).","DOI":"10.1016\/j.neuron.2025.03.008"},{"key":"64540_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336896.2015.1011885","volume":"9","author":"V Romano","year":"2015","unstructured":"Romano, V., Quadri, Z., Baralle, F. E. & Buratti, E. The structural integrity of TDP-43 N-terminus is required for efficient aggregate entrapment and consequent loss of protein function. Prion 9, 1\u20139 (2015).","journal-title":"Prion"},{"key":"64540_CR42","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","volume":"46","author":"H Kroth","year":"2019","unstructured":"Kroth, H. et al. Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies. Eur. J. Nucl. Med. Mol. Imaging 46, 2178\u20132189 (2019).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"64540_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.807435","volume":"16","author":"R Harada","year":"2022","unstructured":"Harada, R. et al. Imaging of reactive Astrogliosis by Positron Emission Tomography. Front. Neurosci. 16, 807435 (2022).","journal-title":"Front. Neurosci."},{"key":"64540_CR44","doi-asserted-by":"publisher","unstructured":"Cordts, I. et al. TDP-43 Proteinopathy specific biomarker development. Cells 12, https:\/\/doi.org\/10.3390\/cells12040597 (2023).","DOI":"10.3390\/cells12040597"},{"key":"64540_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-024-00419-8","volume":"13","author":"JI Lopez-Carbonero","year":"2024","unstructured":"Lopez-Carbonero, J. I. et al. In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use. Transl. Neurodegener. 13, 29 (2024).","journal-title":"Transl. Neurodegener."},{"key":"64540_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00259-019-04488-0","volume":"47","author":"SP McCluskey","year":"2020","unstructured":"McCluskey, S. P., Plisson, C., Rabiner, E. A. & Howes, O. Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development. Eur. J. Nucl. Med. Mol. Imaging 47, 451\u2013489 (2020).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"64540_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","volume":"30","author":"VW Pike","year":"2009","unstructured":"Pike, V. W. PET radiotracers: crossing the blood-brain barrier and surviving metabolism. Trends Pharm. Sci. 30, 431\u2013440 (2009).","journal-title":"Trends Pharm. Sci."},{"key":"64540_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones, T. L., Attems, J. & Thal, D. R. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 134, 187\u2013205 (2017).","journal-title":"Acta Neuropathol."},{"key":"64540_CR49","doi-asserted-by":"publisher","unstructured":"Kulichikhin, K. Y., Malikova, O. A., Zobnina, A. E., Zalutskaya, N. M. & Rubel, A. A. Interaction of Proteins Involved in Neuronal Proteinopathies. Life 13, https:\/\/doi.org\/10.3390\/life13101954 (2023).","DOI":"10.3390\/life13101954"},{"key":"64540_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ana.26711","volume":"94","author":"PT Nelson","year":"2023","unstructured":"Nelson, P. T., Schneider, J. A., Jicha, G. A., Duong, M. T. & Wolk, D. A. When Alzheimer\u2019s is LATE: Why does it matter?. Ann. Neurol. 94, 211\u2013222 (2023).","journal-title":"Ann. Neurol."},{"key":"64540_CR51","doi-asserted-by":"publisher","unstructured":"Young, A. L. et al. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies. medRxiv, https:\/\/doi.org\/10.1101\/2023.01.31.23285242 (2023).","DOI":"10.1101\/2023.01.31.23285242"},{"key":"64540_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-017-0471-3","volume":"5","author":"A Yousef","year":"2017","unstructured":"Yousef, A. et al. Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration. Acta Neuropathol. Commun. 5, 68 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"64540_CR53","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/brain\/awab368","volume":"145","author":"A Kawles","year":"2022","unstructured":"Kawles, A. et al. Cortical and subcortical pathological burden and neuronal loss in an autopsy series of FTLD-TDP-type C. Brain 145, 1069\u20131078 (2022).","journal-title":"Brain"},{"key":"64540_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-016-0335-2","volume":"4","author":"R Takeuchi","year":"2016","unstructured":"Takeuchi, R. et al. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes. Acta Neuropathol. Commun. 4, 61 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"64540_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s00401-024-02753-7","volume":"147","author":"JL Robinson","year":"2024","unstructured":"Robinson, J. L. et al. Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies. Acta Neuropathol. 147, 104 (2024).","journal-title":"Acta Neuropathol."},{"key":"64540_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106050","volume":"179","author":"T Afroz","year":"2023","unstructured":"Afroz, T. et al. Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS\/FTD. Neurobiol. Dis. 179, 106050 (2023).","journal-title":"Neurobiol. Dis."},{"key":"64540_CR57","doi-asserted-by":"publisher","first-page":"e55031","DOI":"10.1371\/journal.pone.0055031","volume":"8","author":"DP Bagchi","year":"2013","unstructured":"Bagchi, D. P. et al. Binding of the radioligand SIL23 to alpha-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent. PLoS One 8, e55031 (2013).","journal-title":"PLoS One"},{"key":"64540_CR58","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","volume":"69","author":"GA Jicha","year":"1997","unstructured":"Jicha, G. A. et al. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer\u2019s disease. J. Neurochem. 69, 2087\u20132095 (1997).","journal-title":"J. Neurochem."},{"key":"64540_CR59","doi-asserted-by":"publisher","unstructured":"Rostagno, A. & Ghiso, J. Isolation and biochemical characterization of amyloid plaques and paired helical filaments. Curr. Protoc. Cell Biol. Chapter 3, Unit 3 33 33 33 31-33, https:\/\/doi.org\/10.1002\/0471143030.cb0333s44 (2009).","DOI":"10.1002\/0471143030.cb0333s44"},{"key":"64540_CR60","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64540_CR61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/ana.24517","volume":"78","author":"M Marquie","year":"2015","unstructured":"Marquie, M. et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann. Neurol. 78, 787\u2013800 (2015).","journal-title":"Ann. Neurol."},{"key":"64540_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fninf.2012.00027","volume":"6","author":"T Rohlfing","year":"2012","unstructured":"Rohlfing, T. et al. The INIA19 Template and NeuroMaps Atlas for primate brain image parcellation and spatial normalization. Front Neuroinform. 6, 27 (2012).","journal-title":"Front Neuroinform."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64540-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64540-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:02:29Z","timestamp":1761296549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64540-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64540"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64540-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EV is a consultant of AC Immune SA. EC, ND, DC, TM, JKB, MR, AMS, TJA, CD, MYR, HK, FCA, RLC, TA, AP, MKV and TS are or were employees of AC Immune SA at the time of their contribution to this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9358"}}